(Q43427868)

23 November 2017

title

Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years (English)

1 reference

23 November 2017

1 reference

1

Hiroyuki Yoshikawa

1 reference

23 November 2017

Keiko Ebihara

2

1 reference

23 November 2017

Yoshiyuki Tanaka

series ordinal

3

1 reference

23 November 2017

Kiichiro Noda

series ordinal

4

1 reference

23 November 2017

publication date

7 March 2013

1 reference

23 November 2017

1 reference

23 November 2017

volume

104

1 reference

23 November 2017

issue

4

1 reference

23 November 2017

page(s)

465-472

1 reference

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

23 November 2017

cites work

1 reference

Hand-genital transmission of genital warts? An analysis of prevalence data

21 January 2018

1 reference

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

21 January 2018

1 reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

Efficacy and other milestones for human papillomavirus vaccine introduction

21 January 2018

1 reference

Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer

21 January 2018

1 reference

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

21 January 2018

1 reference

The 2001 Bethesda System: terminology for reporting results of cervical cytology

21 January 2018

1 reference

2001 Consensus Guidelines for the management of women with cervical cytological abnormalities

21 January 2018

1 reference

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

21 January 2018

1 reference

Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.

21 January 2018

1 reference

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

21 January 2018

1 reference

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years

21 January 2018

1 reference

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types

21 January 2018

1 reference

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.

21 January 2018

1 reference

Evaluation of the HPV 18 antibody response in Gardasil® vaccinees after 48 mo using a pseudovirion neutralization assay

21 January 2018

1 reference

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

21 January 2018

1 reference

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.

21 January 2018

1 reference

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

21 January 2018

1 reference

Recent progress in epidemiologic research of uterine cancer

21 January 2018

1 reference

12 December 2020

Human papillomavirus DNA in female condylomata

1 reference

12 December 2020

Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18

1 reference

12 December 2020

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay

1 reference

12 December 2020

Do we need a different strategy for HPV screening and vaccination in East Asia?

1 reference

12 December 2020

Identifiers

DOI

10.1111/CAS.12106

1 reference

23 November 2017

1 reference